Table 5 Open in new tab Univariate and...

	Univariate	P-value	Multivariate	P-value
Age	1.03 (1.0–1.05)	0.017	0.99 (0.96–1.03)	0.623
Male	1.24 (0.69–2.25)	0.478
BMI	0.98 (0.92–1.04)	0.570
Logistic EuroSCORE I	1.0 (0.99–1.02)	0.294
CHA₂DS₂-VASc score	0.9 (0.77–1.08)	0.273
HAS-BLED score	1.07 (0.85–1.35)	0.558
CAD	1.47 (0.81–2.65)	0.202
AF	1.85 (0.99–3.45)	0.054	0.75 (0.30–1.85)	0.535
pAVK	1.69 (0.77–3.72)	0.193
cAVK	2.08 (0.79–5.51)	0.140
OSAS	2.59 (1.16–5.77)	0.02	2.51 (1.08–5.84)	0.033
COPD	1.22 (0.57–2.66)	0.624
Dialysis	1.90 (0.43–8.40)	0.398
Anaemia	2.73 (1.40–5.32)	0.003	1.41 (0.61–3.28)	0.420
Immunotherapy	0.0
Oesophageal pathologies	1.18 (0.41–3.38)	0.764
Diabetes mellitus	0.83 (0.42–1.66)	0.599
GFR	0.98 (0.97–0.99)	0.002	0.99 (0.98–1.01)	0.263
Haemoglobin	0.78 (0.69–0.88)	<0.001	0.81 (0.67–0.98)	0.025
INR	0.99 (0.98–1.0)	0.013	1.0 (0.99–1.02)	0.847
DAPT	0.32 (0.10–1.05)	0.06	0.43 (0.09–1.95)	0.271
Oral anticoagulation	2.48 (1.35–4.55)	0.003	1.97 (0.9–4.3)	0.074
Procedure type	0.71 (0.48–1.05)	0.088	1.95 (0.94–4.04)	0.889
Procedure time	1.01 (1.01–1.02)	<0.001	1.01 (1.0–1.01)	0.056

Univariate

P-value

Multivariate

P-value

OR (95% CI)

Age

1.03 (1.0–1.05)

0.017

0.99 (0.96–1.03)

0.623

Male

1.24 (0.69–2.25)

0.478

BMI

0.98 (0.92–1.04)

0.570

Logistic EuroSCORE I

1.0 (0.99–1.02)

0.294

CHA₂DS₂-VASc score

0.9 (0.77–1.08)

0.273

HAS-BLED score

1.07 (0.85–1.35)

0.558

CAD

1.47 (0.81–2.65)

0.202

1.85 (0.99–3.45)

0.054

0.75 (0.30–1.85)

0.535

pAVK

1.69 (0.77–3.72)

0.193

cAVK

2.08 (0.79–5.51)

0.140

OSAS

2.59 (1.16–5.77)

0.02

2.51 (1.08–5.84)

0.033

COPD

1.22 (0.57–2.66)

0.624

Dialysis

1.90 (0.43–8.40)

0.398

Anaemia

2.73 (1.40–5.32)

0.003

1.41 (0.61–3.28)

0.420

Immunotherapy

0.0

Oesophageal pathologies

1.18 (0.41–3.38)

0.764

Diabetes mellitus

0.83 (0.42–1.66)

0.599

GFR

0.98 (0.97–0.99)

0.002

0.99 (0.98–1.01)

0.263

Haemoglobin

0.78 (0.69–0.88)

<0.001

0.81 (0.67–0.98)

0.025

INR

0.99 (0.98–1.0)

0.013

1.0 (0.99–1.02)

0.847

DAPT

0.32 (0.10–1.05)

0.06

0.43 (0.09–1.95)

0.271

Oral anticoagulation

2.48 (1.35–4.55)

0.003

1.97 (0.9–4.3)

0.074

Procedure type

0.71 (0.48–1.05)

0.088

1.95 (0.94–4.04)

0.889

Procedure time

1.01 (1.01–1.02)

<0.001

1.01 (1.0–1.01)

0.056

	Univariate	P-value	Multivariate	P-value
Age	1.03 (1.0–1.05)	0.017	0.99 (0.96–1.03)	0.623
Male	1.24 (0.69–2.25)	0.478
BMI	0.98 (0.92–1.04)	0.570
Logistic EuroSCORE I	1.0 (0.99–1.02)	0.294
CHA₂DS₂-VASc score	0.9 (0.77–1.08)	0.273
HAS-BLED score	1.07 (0.85–1.35)	0.558
CAD	1.47 (0.81–2.65)	0.202
AF	1.85 (0.99–3.45)	0.054	0.75 (0.30–1.85)	0.535
pAVK	1.69 (0.77–3.72)	0.193
cAVK	2.08 (0.79–5.51)	0.140
OSAS	2.59 (1.16–5.77)	0.02	2.51 (1.08–5.84)	0.033
COPD	1.22 (0.57–2.66)	0.624
Dialysis	1.90 (0.43–8.40)	0.398
Anaemia	2.73 (1.40–5.32)	0.003	1.41 (0.61–3.28)	0.420
Immunotherapy	0.0
Oesophageal pathologies	1.18 (0.41–3.38)	0.764
Diabetes mellitus	0.83 (0.42–1.66)	0.599
GFR	0.98 (0.97–0.99)	0.002	0.99 (0.98–1.01)	0.263
Haemoglobin	0.78 (0.69–0.88)	<0.001	0.81 (0.67–0.98)	0.025
INR	0.99 (0.98–1.0)	0.013	1.0 (0.99–1.02)	0.847
DAPT	0.32 (0.10–1.05)	0.06	0.43 (0.09–1.95)	0.271
Oral anticoagulation	2.48 (1.35–4.55)	0.003	1.97 (0.9–4.3)	0.074
Procedure type	0.71 (0.48–1.05)	0.088	1.95 (0.94–4.04)	0.889
Procedure time	1.01 (1.01–1.02)	<0.001	1.01 (1.0–1.01)	0.056

Table 5

Open in new tab

Univariate and multivariate regression analysis

	Univariate	P-value	Multivariate	P-value
OR (95% CI)	OR (95% CI)	P-value	Multivariate	P-value
Age	1.03 (1.0–1.05)	0.017	0.99 (0.96–1.03)	0.623
Male	1.24 (0.69–2.25)	0.478
BMI	0.98 (0.92–1.04)	0.570
Logistic EuroSCORE I	1.0 (0.99–1.02)	0.294
CHA₂DS₂-VASc score	0.9 (0.77–1.08)	0.273
HAS-BLED score	1.07 (0.85–1.35)	0.558
CAD	1.47 (0.81–2.65)	0.202
AF	1.85 (0.99–3.45)	0.054	0.75 (0.30–1.85)	0.535
pAVK	1.69 (0.77–3.72)	0.193
cAVK	2.08 (0.79–5.51)	0.140
OSAS	2.59 (1.16–5.77)	0.02	2.51 (1.08–5.84)	0.033
COPD	1.22 (0.57–2.66)	0.624
Dialysis	1.90 (0.43–8.40)	0.398
Anaemia	2.73 (1.40–5.32)	0.003	1.41 (0.61–3.28)	0.420
Immunotherapy	0.0
Oesophageal pathologies	1.18 (0.41–3.38)	0.764
Diabetes mellitus	0.83 (0.42–1.66)	0.599
GFR	0.98 (0.97–0.99)	0.002	0.99 (0.98–1.01)	0.263
Haemoglobin	0.78 (0.69–0.88)	<0.001	0.81 (0.67–0.98)	0.025
INR	0.99 (0.98–1.0)	0.013	1.0 (0.99–1.02)	0.847
DAPT	0.32 (0.10–1.05)	0.06	0.43 (0.09–1.95)	0.271
Oral anticoagulation	2.48 (1.35–4.55)	0.003	1.97 (0.9–4.3)	0.074
Procedure type	0.71 (0.48–1.05)	0.088	1.95 (0.94–4.04)	0.889
Procedure time	1.01 (1.01–1.02)	<0.001	1.01 (1.0–1.01)	0.056

	Univariate	P-value	Multivariate	P-value
OR (95% CI)	OR (95% CI)	P-value	Multivariate	P-value
Age	1.03 (1.0–1.05)	0.017	0.99 (0.96–1.03)	0.623
Male	1.24 (0.69–2.25)	0.478
BMI	0.98 (0.92–1.04)	0.570
Logistic EuroSCORE I	1.0 (0.99–1.02)	0.294
CHA₂DS₂-VASc score	0.9 (0.77–1.08)	0.273
HAS-BLED score	1.07 (0.85–1.35)	0.558
CAD	1.47 (0.81–2.65)	0.202
AF	1.85 (0.99–3.45)	0.054	0.75 (0.30–1.85)	0.535
pAVK	1.69 (0.77–3.72)	0.193
cAVK	2.08 (0.79–5.51)	0.140
OSAS	2.59 (1.16–5.77)	0.02	2.51 (1.08–5.84)	0.033
COPD	1.22 (0.57–2.66)	0.624
Dialysis	1.90 (0.43–8.40)	0.398
Anaemia	2.73 (1.40–5.32)	0.003	1.41 (0.61–3.28)	0.420
Immunotherapy	0.0
Oesophageal pathologies	1.18 (0.41–3.38)	0.764
Diabetes mellitus	0.83 (0.42–1.66)	0.599
GFR	0.98 (0.97–0.99)	0.002	0.99 (0.98–1.01)	0.263
Haemoglobin	0.78 (0.69–0.88)	<0.001	0.81 (0.67–0.98)	0.025
INR	0.99 (0.98–1.0)	0.013	1.0 (0.99–1.02)	0.847
DAPT	0.32 (0.10–1.05)	0.06	0.43 (0.09–1.95)	0.271
Oral anticoagulation	2.48 (1.35–4.55)	0.003	1.97 (0.9–4.3)	0.074
Procedure type	0.71 (0.48–1.05)	0.088	1.95 (0.94–4.04)	0.889
Procedure time	1.01 (1.01–1.02)	<0.001	1.01 (1.0–1.01)	0.056

AF, atrial fibrillation; BMI, body mass index; CAD, coronary artery disease; cAVK, cerebral artery vascular disease; COPD, chronic obstructive pulmonary disease; DAPT, dual antiplatelet therapy; GFR, glomerular filtration rate; OSAS, obstructive sleep apnoea syndrome; pAVK, peripheral artery vascular disease. Parameters with a P < 0.1 in the univariate analysis were included in the multivariate regression analysis. A P-value <0.05 was considered statistically significant.

This Feature Is Available To Subscribers Only